Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8413442 | 0.87 | PPARD (0.36) | TSHRPPARDTP53TDP1 | |
| SCHEMBL12740886 | 0.82 | PPARD (0.39) | TSHRPPARDTP53TDP1GRM4 | |
| SCHEMBL3820534 | 0.82 | LPAR3 (0.38) | HMGCRSMPD1LPAR1LPAR3LPAR2 | |
| SCHEMBL13557185 | 0.81 | PPARD (0.32) | PPARD | |
| SCHEMBL28881876 | 0.81 | TSHR (0.42) | TSHRPPARDTP53TDP1SMPD1 | |
| SCHEMBL19940080 | 0.81 | BTN3A1 (0.35) | TSHRLPAR1LPAR3LPAR2 | |
| Diethyl Hydrogen Phosphate SCHEMBL31413319 | 0.79 | TP53 (0.52) | TSHRPPARDTP53TDP1CA12 | |
| SCHEMBL990567 | 0.79 | — | — | |
| SCHEMBL22588854 | 0.79 | TSHR (0.40) | TSHRPPARDTP53TDP1HMGCR | |
| SCHEMBL19940081 | 0.79 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12296304-B2 | Membrane for water filtration | AQUAPORIN A/S (DK) | 2025-05-13 | — | — | US | disclosed |
| EP-4277731-B1 | PROCESS FOR PREPARING A MEMBRANE | AQUAPORIN AS (DK) | 2024-10-09 | — | — | EP | disclosed |
| US-20240058768-A1 | MEMBRANE FOR WATER FILTRATION | AQUAPORIN A/S (DK) | 2024-02-22 | — | — | US | disclosed |
| EP-4277731-A1 | MEMBRANE FOR WATER FILTRATION | Aquaporin A/S (DK) | 2023-11-22 | — | — | EP | disclosed |
| CN-116745025-A | membrane for water filtration | 水通道蛋白有限公司 | 2023-09-12 | — | — | CN | disclosed |
| WO-2022152748-A1 | MEMBRANE FOR WATER FILTRATION | AQUAPORIN A/S (DK) | 2022-07-21 | — | — | WO | disclosed |
| WO-2018140648-A1 | PYRROLOPYRIMIDINE ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER | JACOBSEN ERIC JON (US) | 2018-08-02 | — | — | WO | disclosed |
| US-8106209-B2 | Substituted aminothiazole prodrugs of compounds with anti-HCV activity | ACHILLION PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |
| US-20110086813-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2011-04-14 | — | — | US | disclosed |
| US-7745625-B2 | Prodrugs of piperazine and substituted piperidine antiviral agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-06-29 | — | — | US | disclosed |
| US-6723241-B2 | COMPRISING A POLYAMIDE LAYER ON A POROUS SUPPORT WHERE THE POLYAMIDE LAYER IS COMPLEXED OR HYDROGEN BONDED TO A PHOSPHORUS-CONTAINING COMPOUND; IMPROVED FLUX AND/OR REJECTION RATE; FILTERS; NANOFILTRATION AND REVERSE OSMOSIS | DOW GLOBAL TECHNOLOGIES INC. | 2004-04-20 | — | — | US | disclosed |
| CN-1441693-A | Composite film and method for producing same | DOW GLOBAL TECHNOLOGY CO (US) | 2003-09-10 | — | — | CN | disclosed |
| US-20030116498-A1 | Composite membrane and method for making the same | THE DOW CHEMICAL COMPANY | 2003-06-26 | — | — | US | disclosed |
| US-6562266-B2 | Composite membrane and method for making the same | DOW GLOBAL TECHNOLOGIES INC. | 2003-05-13 | — | — | US | disclosed |
| EP-1276551-A2 | COMPOSITE MEMBRANE AND METHOD FOR MAKING THE SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-01-22 | — | — | EP | disclosed |
| US-20020113008-A1 | Composite membrane and method for making the same | THE DOW CHEMICAL COMPANY | 2002-08-22 | — | — | US | disclosed |
| US-6337018-B1 | COATING POROUS SUPPORT WITH SOLUTION OF POLYFUNCTIONAL AMINE AND SOLUTION OF POLYFUNCTIONAL ACYL HALIDE WHICH REACT TO FORM POLYAMIDE LAYER, INCLUDING STEP OF CONTACTING PHOSPHOROUS COMPOUND WITH ACYL HALIDE BEFORE REACTING WITH AMINE | THE DOW CHEMICAL COMPANY | 2002-01-08 | — | — | US | disclosed |
| US-20010050252-A1 | Composite membrane and method for making the same | DOW GLOBAL TECHNOLOGIES LLC | 2001-12-13 | — | — | US | disclosed |
| WO-2001078882-A2 | COMPOSITE MEMBRANE AND METHOD FOR MAKING THE SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2001-10-25 | — | — | WO | disclosed |
| US-3954755-A | INSECTICIDES, ACARICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086813-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | REL, RELA, NFKB1 | TSHR 4414/4885PPARD 4104/4885TP53 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.